BioLineRx Ltd.

NASDAQ: BLRX · Real-Time Price · USD
4.67
0.45 (10.66%)
At close: Jun 04, 2025, 3:59 PM
4.52
-3.21%
Pre-market: Jun 05, 2025, 07:49 AM EDT
10.66%
Bid 4.48
Market Cap 17.38M
Revenue (ttm) 28.94M
Net Income (ttm) -9.22M
EPS (ttm) -6
PE Ratio (ttm) -0.78
Forward PE -16.42
Analyst Buy
Ask 4.7
Volume 262,668
Avg. Volume (20D) 622,077
Open 4.13
Previous Close 4.22
Day's Range 4.00 - 4.73
52-Week Range 2.30 - 35.60
Beta 0.86

About BLRX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BLRX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BLRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

BioLineRx has released their quartely earnings on May 27, 2025:
  • Revenue of $255K misses estimates by $1.23M, with -96.28% YoY decline.
  • EPS of 0 exceeds estimates by 1.06, with 100.00% YoY growth.
  • 5 days ago
    +38.52%
    BioLineRx shares are trading higher after the comp... Unlock content with Pro Subscription
    4 months ago
    -16.8%
    BioLineRx shares are trading lower after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.